At a glance
- Originator Agouron Pharmaceuticals; University of Newcastle upon Tyne
- Developer University of Newcastle upon Tyne
- Class Antineoplastics; Quinazolines; Small molecules
- Mechanism of Action Poly(ADP-ribose) polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer